Steward Partners Investment Advisory, LLC Lantern Pharma Inc. Transaction History

Steward Partners Investment Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$4.19 - $6.04 $628 - $906	-150 Reduced 33.33%	300 $1,000
Q2 2022 Aug 04, 2022	BUY	$4.82 - $7.45 $723 - $1,117	150 Added 50.0%	450 $3,000
Q3 2021 Nov 12, 2021	BUY	$10.53 - $14.93 $526 - $746	50 Added 20.0%	300 $3,000
Q2 2021 Aug 13, 2021	BUY	$12.94 - $19.89 $3,235 - $4,972	250 New	250 $4,000

1.26M

42.8K

5.6K

Ticker LTRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,830,900
Market Cap $40.9M
Description
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.